Ua pop diva who made the never conventional beauty, therefore authentic, an artistic and aesthetic manifesto. And a large pharmaceutical group which celebrates its cutting-edge beliefs and continuous innovations with an important anniversary. The Lady Gaga’s sold out concert-event in Milan it was the opportunity to IBSA and IBSA Dermadermoaesthetics division, official sponsor of the evening, to reiterate the commitment to research in the field of aesthetic medicine in favor of a concept of avant-garde beauty, beyond any standard.

A revolutionary aesthetic vision

10 years of cutting edge. It was the 2015 when i IBSA laboratories they patented the forerunner of treatment most requested today to aesthetic doctors: biorevitalization, that so-called “small touch-up that is there, but you can’t see it”, and yet, it makes you more radiant, toned, “glowy”. Patented technology NAHYCO® Hybrid Technology of IBSA was a pioneer in uniquely combine a complex of high and low molecular weight hyaluronic acids, stabilized through a thermal process without any chemical agent, capable of respecting the physiology of the skin and integrating optimally into the tissues.

Result? The treatment Profhilo®, a regenerative boost that is not limited to correcting or working on volumes, but stimulates tissues to regain their natural vitalityenergy and brightness. A true revolution in the approach to injectable aesthetics, for the first time, regenerative. It’s integratedcapable of combining remodeling, firmness and improvement of the quality of the skin. A paradigm shift, from corrective to proactive. AND an important step forward in aesthetic medicine, increasingly oriented towards skin-longevity, for a long time.

Beauty is not just what appears, but what is perceived, an energy that comes from within”: this is the message that IBSA carries forward with the motto “Beauty Beyond Standards”, renewing the commitment to an approach that respects the uniqueness of each face.

In 2025 IBSA celebrates two anniversaries: The 40° year since the acquisition by the current President and CEO Arturo Licenziati, who transformed the company into a multinational with 10 therapeutic areas and 20 forward-looking branches in Europe, China and the United States, and, also, ten years since the launch of Profhilo®, in continuous development guided by science, clinical sensitivity and listening to patients.

It all started from an intuition: to bring hyaluronic acid, already used in the therapeutic field, into the world of aesthetics, with the ambition to overcome the limits of traditional formulations.

IBSA Italia celebrates 10 years of NAHYCO®, hi-tech aesthetic medicine technology

Technology and continuous investments in research and development, and an eye to the future, with energy. Medicines, medical devices, supplements… All the products of the IBSA group have a Made in Italy production, ensuring complete control of the life cycle of the products.

Looking to the future, therefore, towards a more conscious, ethical, regenerative beauty. And who, better than the Lady of pop, Gaga, with her visionary image and could an overwhelming show be a symbol of this? «I promise I’ll be here again, in twenty years, in Milan: I will be older, more adult, but always myself” said Gaga, at the end of the concert. Everyone’s dream from the aesthetic doctor, or not?

ttn-13